UK markets closed
NIKKEI 225
38,073.98 -128.42 (-0.34%) HANG SENG
18,537.81 +223.91 (+1.22%) CRUDE OIL
79.57 +0.31 (+0.39%) GOLD FUTURES
2,353.10 +12.80 (+0.55%) DOW
39,387.76 +331.36 (+0.85%) Bitcoin GBP
49,936.03 +878.79 (+1.79%)
YMAB May 2024 17.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:10PM EDT. Market open.
| Previous close | 1.2000 |
| Open | 1.1000 |
| Bid | 0.0000 |
| Ask | 0.1000 |
| Strike | 17.50 |
| Expiry date | 2024-05-17 |
| Day's range | 1.0500 - 1.8000 |
| Contract range | N/A |
| Volume | |
| Open interest | 205 |
Insider MonkeyY-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2024 Earnings Call Transcript
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2024 Earnings Call Transcript May 8, 2024 Y-mAbs Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to Y-mAbs Therapeutics Inc. Earnings Conference Call for the First Quarter of 2024. […]
- GuruFocus.com
Y-mAbs Therapeutics Inc (YMAB) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
Amidst leadership changes and competitive pressures, Y-mAbs Therapeutics Inc reports robust U.S. sales growth and strategic global expansions.
- Thomson Reuters StreetEvents
Q1 2024 Y-mAbs Therapeutics Inc Earnings Call
Q1 2024 Y-mAbs Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.